Cannabis consumption and psychosis or schizophrenia development

@article{OrtizMedina2018CannabisCA,
  title={Cannabis consumption and psychosis or schizophrenia development},
  author={Mar{\'i}a Bettina Ortiz-Medina and Marta Perea and Julio Torales and Antonio Ventriglio and Giovanna Vitrani and Lourdes Aguilar and Carlos Roncero},
  journal={International Journal of Social Psychiatry},
  year={2018},
  volume={64},
  pages={690 - 704}
}
Objective: Cannabis consumption produces psychopathology, in some cases psychotic episodes, which are of our interest in this work. However, the relationship between cannabis use and psychosis has not been fully elucidated. The objectives of this work are to (1) review the current state of knowledge on the association of cannabis use with the risk of the development of psychosis or psychotic symptoms in people without schizophrenia and (2) assess the consistency of the hypothesis that cannabis… Expand
Cannabis and Psychosis: A Review of the Risk Factors Involved
TLDR
A significant inverse relationship exists between cannabidiol (CBD) and psychosis: cannabodiol is associated with less psychotic symptoms and manifests antipsychotic properties. Expand
Cannabis use in individuals at clinical high-risk for psychosis: a comprehensive review
TLDR
Cannabis use has not been thoroughly researched regarding frequency and dose of use, and how other factors, such as symptoms, are associated with cannabis in CHR individuals. Expand
Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls
TLDR
FEP patients are particularly sensitive to increased psychotic-like, but not euphoric experiences, at higher levels of cannabis use compared to controls, which suggests a specific psychotomimetic response in FEP patients related to heavy cannabis use. Expand
Medical Cannabis in Children
TLDR
The main risks associated with use of Δ9-tetrahydrocannabinol (THC) and CBD in the pediatric population are described, as well as the debate regarding the use of whole-plant extract to retain a possible “entourage effect” as opposed to pure cannabinoids that are more standardized and reproducible. Expand
Cannabis Use Induces Distinctive Proteomic Alterations in Olfactory Neuroepithelial Cells of Schizophrenia Patients
TLDR
Findings indicate that RNA-related proteins might be relevant to understand the influence of cannabis use on schizophrenia (SCZ), and are correlated with cognitive performance and clinical scores. Expand
Co-occurrence across time and space of drug- and cannabinoid- exposure and adverse mental health outcomes in the National Survey of Drug Use and Health: combined geotemporospatial and causal inference analysis
TLDR
Cannabis use-MH data are consistent with causal relationships in the forward direction and include dose-response and temporal-sequential relationships and preventative action to reduce cannabis use is indicated. Expand
Digital Health Around Clinical High Risk and First-Episode Psychosis
TLDR
There is still a need for further research on how technology can predict and model relapse, but there are simple ways to begin incorporating technology for relapse prediction in clinical care. Expand
The endocannabinoid system in migraine: from bench to pharmacy and back
TLDR
The endocannabinoid system qualifies as an interesting area of research worth exploration in the quest for therapeutic targets for the treatment of migraine, growing preclinical evidence and initial clinical findings suggest. Expand
Psychotic disorders hospitalizations associated with cannabis abuse or dependence: A nationwide big data analysis
TLDR
The hospital panorama of psychotic disorders (PD) with cannabis use (CU) trends in all Portuguese public hospitals is described and correlated. Expand
Δ-9-Tetrahydrocannabinol treatment during adolescence and alterations in the inhibitory networks of the adult prefrontal cortex in mice subjected to perinatal NMDA receptor antagonist injection and to postweaning social isolation
TLDR
The results support previous work showing alterations in parameters involving interneurons in similar animal models and schizophrenic patients, and suggest a protective effect of cannabis use during adolescence. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 89 REFERENCES
[Cannabis consumption and development of psychosis: state of the art].
TLDR
The data demonstrate that there are both temporal and dose-response relationships, and that early initiation of cannabis use is highly correlated with the development of psychotic symptoms, to the extent that some studies suggest a causal relationship. Expand
Cannabis use and the risk of later schizophrenia: a review.
TLDR
Antecedent cannabis use appears to act as a risk factor in the onset of schizophrenia, especially in vulnerable people, but also in people without prior history. Expand
Cannabis use and psychotic disorders: an update.
TLDR
This paper evaluates three hypotheses about the relationship between cannabis use and psychosis in the light of recent evidence from prospective epidemiological studies, finding reasonable evidence for the third hypothesis that cannabis use exacerbates psychosis. Expand
Cannabis Use and Psychosis: A Review of Clinical and Epidemiological Evidence ∗
TLDR
It is still unclear whether this means that cannabis use precipitates schizophrenia, whether cannabis use is a form of ‘self-medication’, or whether the association is due to the use of other drugs, such as amphetamines, which heavy cannabis users are more likely to use. Expand
Cannabis use and risk of psychosis: an etiological link?*
TLDR
A dose-response relationship was found between cannabis exposure and risk of psychosis, and this association was independent from potential confounding factors such as exposure to other drugs and pre-existence of psychotic symptoms. Expand
Causal association between cannabis and psychosis: examination of the evidence
TLDR
Cases of psychotic disorder could be prevented by discouraging cannabis use among vulnerable youths and research is needed to understand the mechanisms by which cannabis causes psychosis. Expand
[A review about cannabis use like as risk factor of schizophrenia].
TLDR
It is considered that the use of cannabis is clearly associated with the inducement of psychotic symptoms and is, possibly, a risk factor of schizophrenia in people with a genetic or psychosocial vulnerability, preventive methods being necessary in high-risk groups. Expand
Cannabis and psychosis/schizophrenia: human studies
TLDR
Converting lines of evidence suggest that cannabinoids can produce a full range of transient schizophrenia-like positive, negative, and cognitive symptoms in some healthy individuals, and novel hypotheses including the role of cannabinoids on neurodevelopmental processes relevant to psychotic disorders are being studied. Expand
Cannabis and Psychosis: What is the Link?
TLDR
Although there is evidence that cannabis use increases the risk of developing psychotic symptoms, the causal nature of this association remains unclear, and this conclusion should be mitigated by uncertainty arising from cannabis use assessment, psychosis measurement, reverse causality and control of residual confounding. Expand
Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study
TLDR
Cannabis use interacts with psychosis vulnerability in their effects on experience of psychosis in daily life and there is no evidence that use of cannabis is increased following occurrence of psychotic experiences as would be expected by the self-medication model. Expand
...
1
2
3
4
5
...